RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Special Article | 
Geoffrey S. Ginsburg, MD, PhD; Richard P. Konstance, MD; Jennifer S. Allsbrook, BSPH; et al.
Arch Intern Med. 2005;165(20):2331-2336. doi:10.1001/archinte.165.20.2331.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
Health Agencies Update  | 
Public-Private Groups Seek Drug Targets
Bridget M. Kuehn, MSJ
Viewpoint  | 
The Accelerated Approval of Oncologic Drugs:  Lessons From Ponatinib
Vinay Prasad, MD; Sham Mailankody, MB, BS
Medical News & Perspectives  | 
Another Novel Oral Anticoagulant Matches Warfarin
Mike Mitka, MSJ
JAMA Dermatology
Case Report/Case Series  | 
Identification of a Novel Complex BRAF Mutation Associated With Major Clinical Response to Vemurafenib in a Patient With Metastatic Melanoma
Benoit Busser, PharmD, PhD; Marie Therese Leccia, MD, PhD; Guillaume Gras-Combe, MD; et al.